Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15632-15649
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15632
Table 2 Regulation of gene expression by probiotics in inflammatory diseases of the gut
StudyProbiotic strainGenes involved
Inflammatory bowel disease
Disfrutti et al[71]VSL#3IL-10, TNFRSF1B
Ghadimi et al[72]B. breve (DSMZ 20213) and L. rhamnosus GGIL-17 and IL-23
Grimoud et al[73]B. breve and L. lactisTLR-4
Chen et al[74]Saccharomyces boulardiiVEGF
Bassaganya-Riera et al[75]VSL#3TNF-α, COX-2, and PPAR-γ
Ulcerative colitis
Garrido-Mesa et al[76]E. coli Nissle 1917TNF-α, IL-1β, IL2, MIP-2, MCP-1, ICAM-1, MUC3, and ZO-1
Claes et al[77]L. rhamnosus GG wild type and mutantTLR-2
Miyauchi et al[78]L. rhamnosus OLL2838ZO-1
Mariman et al[79]L. plantarum NCIMB8826 and VSL#3Inflammation and immune genes
Amit-Romach et al[80]L. rhamnosus GG and a mixture of probioticsMUC2, IL-6, and TNF-α
Duary et al[81]L. plantarum Lp91IL-4, IL-6,COX-1, COX-2, and TNF-α
Grompone et al[82]L. rhamnosus CNCM I-3690DAF-16/insulin-like pathway
Furrie et al[83]B. longumHuman beta defensins 2, 3, and 4, TNF-α, and IL-1α
Necrotizing enterocolitis
D'Souza et al[84]S. boulardiiCaveolin-1 and NOS-isoforms
Lin et al[85]L. rhamnosus GGGenes with cytoprotective effects
Other inflammatory disorders
Gomi et al[86]B. bifidum BF-1MUC5
Mirpuri et al[87]L. rhamnosus GGIL-10, MIP-2, and TNF-α